Protagonist Therapeutics Inc
NASDAQ:PTGX
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Protagonist Therapeutics Inc
NASDAQ:PTGX
|
US |
|
A
|
Avista Corp
F:AV6
|
US |
|
Pierre et Vacances SA
PAR:VAC
|
FR |
|
Panoro Minerals Ltd
XTSX:PML
|
CA |
|
E
|
Edgio Inc
SWB:LNK
|
US |
|
F
|
Forgent Power Solutions, Inc
NYSE:FPS
|
US |
|
Sage Group PLC
LSE:SGE
|
UK |
|
T
|
Terna Rete Elettrica Nazionale SpA
LSE:0LBM
|
IT |
|
Golden Agri-Resources Ltd
SGX:E5H
|
SG |
|
B
|
Bri-Chem Corp
F:5JN
|
CA |
|
Riedel Resources Ltd
ASX:RIE
|
AU |
|
D
|
Deutsche Telekom AG
MIL:1DTE
|
DE |
|
H
|
Hormel Foods Corp
XMUN:HO7
|
US |
|
Cosmo Energy Holdings Co Ltd
TSE:5021
|
JP |
|
I
|
ITM Power PLC
F:IJ8
|
UK |
|
electroCore, Inc.
NASDAQ:ECOR
|
US |
|
A
|
AstraZeneca PLC
SWB:ZEG
|
UK |
|
Cibox Inter@ctive SA
F:1YH
|
FR |
|
M
|
Mastercraft Boat Holdings Inc
F:1SG
|
US |
Bankruptcy Probability
Protagonist Therapeutics Inc's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Protagonist Therapeutics Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| US |
|
Protagonist Therapeutics Inc
NASDAQ:PTGX
|
8.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| JP |
|
Takara Bio Inc
TSE:4974
|
120.4T JPY |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
458.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
203.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
160.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
121.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
68.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
49.8B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Protagonist Therapeutics Inc's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Protagonist Therapeutics Inc has no debt.
You can find a full breakdown on its Balance Sheet.
